ASTHMA Australia has extended its 15-year partnership with Bird Healthcare for another three years, which will see the duo continue to support pharmacies in improving access to and awareness of inhaled asthma therapies and devices.
The two organisations work together to educate healthcare providers and the wider community on spacers for regular, prescribed asthma treatment and in emergencies.
Without a spacer, 80% of the asthma medicine can be caught in the throat and mouth, never reaching the lungs where it is needed, and resulting in poor health outcomes and medicine wastage costs.
"Our partnership is a shared commitment to improving the lives of people with asthma," said Kate Miranda, Chief Executive of Asthma Australia.
"Spacers can greatly enhance the delivery of asthma medication, making treatment more effective, especially when symptoms suddenly worsen or urgent care is needed."
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 25
